These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7182452)

  • 1. [Metabolic fate of flutoprazepam (KB-509). IV. Pharmacokinetics of flutoprazepam-2-14C and desalkylflutoprazepam-2-14C in dog plasma].
    Kozaki A; Sakurai S; Awata N
    Yakugaku Zasshi; 1982 Dec; 102(12):1177-83. PubMed ID: 7182452
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog.
    Kaplan SA; Alexander K; Jack ML; Puglisi CV; De Silva JA; Lee TL; Weinfeld RE
    J Pharm Sci; 1974 Apr; 63(4):527-32. PubMed ID: 4828698
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of clonazepam and flunitrazepam in blood and urine by electron-capture GLC.
    De Silva JA; Puglisi CV; Munno N
    J Pharm Sci; 1974 Apr; 63(4):520-7. PubMed ID: 4828697
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Blood level, excretion, distribution and metabolism of 14C-triflubazam, a new 1,5-benzodiazepine, in mice and dogs.
    Bechtel WD
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R6. PubMed ID: 4276517
    [No Abstract]   [Full Text] [Related]  

  • 5. Assay and pharmacokinetics of clonazepam in humans.
    Naestoft J; Lund M; Larsen NE; Hvidberg E
    Acta Neurol Scand Suppl; 1973; 53():103-8. PubMed ID: 4519452
    [No Abstract]   [Full Text] [Related]  

  • 6. Propranolol does not alter flutoprazepam kinetics and metabolism in the rat.
    Conti I; Sarati S; Caccia S
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):53-8. PubMed ID: 1936062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects.
    Barzaghi N; Leone L; Monteleone M; Tomasini G; Perucca E
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):293-8. PubMed ID: 2633923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of 14C-loprazolam in animals and man.
    Illing HP; Ings RM; Johnson KI; Fromson JM
    Xenobiotica; 1983 Jul; 13(7):439-49. PubMed ID: 6140793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and ex vivo inhibition by flutoprazepam of [3H]flunitrazepam binding to mouse brain receptors.
    Oki K; Sukamoto T; Ito K; Nose T
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):180-6. PubMed ID: 6148044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacokinetic characteristics of fenazepam in epileptics].
    Maksutova EL; Sariev AK; Zherdev VP; Voronina TA; Zheleznova EV
    Eksp Klin Farmakol; 1994; 57(2):16-8. PubMed ID: 7911365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral long-term treatment with clonazepam (RO 5-4023) in epilepsy in childhood and adolescence].
    Groh C; Rosenmayr FW
    Acta Neurol Scand Suppl; 1973; 53():36-43. PubMed ID: 4519456
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use and effect of Ro 5-4023 (clonazepam) in different forms of epileptic seizures].
    Kruse R; Blankenhorn V
    Acta Neurol Scand Suppl; 1973; 53():60-71. PubMed ID: 4519459
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of clonazepam in the dog.
    Al-Tahan F; Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):180-93. PubMed ID: 6732363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, metabolism and excretion of 14C-monoethyl phthalate (MEP) and 14C-diethyl phthalate (DEP) after single oral and IV administration in the juvenile dog.
    Kao ML; Ruoff B; Bower N; Aoki T; Smart C; Mannens G
    Xenobiotica; 2012 Apr; 42(4):389-97. PubMed ID: 22054055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
    Chen IW; Lin JH
    Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of flunitrazepam, desmethylflunitrazepam and clonazepam in plasma by gas liquid chromatography with an internal standard.
    Cano JP; Guintrand J; Aubert C; Viala A
    Arzneimittelforschung; 1977 Feb; 27(2):338-42. PubMed ID: 16619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with clonazepam (Rivotril) in the treatment of epilepsies in infancy and childhood.
    Martin D; Hirt HR
    Neuropadiatrie; 1973 Jul; 4(3):245-66. PubMed ID: 4584361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.